Clinical trial data disclosure protects the public from preventable harm
In their Joint Response to a consultation by the US Institute of Medicine (IOM), HAI Europe, ISDB, MiEF and TACD encourage the active implementation of a data sharing policy that ensures full public access to clinical data in the US, in alignment with the new European requirements.
PDF attached
Attachment: 20140404_consultationtransparencyiom.pdf